Can lurasidone (Latuda) cause yellow, loose stools?

Latuda Can Cause Diarrhea, But Yellow Loose Stools Are Not a Commonly Reported Side Effect

Based on FDA labeling data, diarrhea occurs in 3-5% of patients taking lurasidone (Latuda), but the specific characteristic of yellow coloration is not documented as a typical presentation 1.

What the Evidence Shows About Latuda and Gastrointestinal Effects

The FDA-approved prescribing information for Latuda clearly lists diarrhea as an adverse reaction, occurring at the following rates:

• Adults with schizophrenia: 2-5% (compared to 1-2% with placebo)
• Adolescents with schizophrenia: 3-5% (compared to 1% with placebo)
• Pediatric patients with bipolar depression: 3% (compared to 2% with placebo)

The most common gastrointestinal side effects with Latuda are actually nausea (10-17%) and vomiting (4-8%), which occur much more frequently than diarrhea 1.

Why Yellow Loose Stools Warrant Further Investigation

The yellow color of stools is not a characteristic feature of Latuda-induced diarrhea and should prompt evaluation for other causes, including:

• Bile acid malabsorption - can cause yellow, watery diarrhea
• Pancreatic exocrine insufficiency - leads to pale/yellow, fatty stools
• Small intestinal bacterial overgrowth (SIBO) - may cause loose, pale stools
• Giardiasis or other infections - can produce yellow diarrhea
• Rapid transit time - insufficient time for bile processing

The 2025 British Society of Gastroenterology guidance emphasizes that new-onset diarrhea during medication treatment warrants investigation for underlying physiological disorders, including lactose intolerance, SIBO, bile acid malabsorption, and pancreatic exocrine insufficiency 2.

Clinical Approach

If a patient on Latuda develops yellow loose stools, consider the following algorithm:

1. Assess severity and duration: Document stool frequency, consistency, presence of blood/mucus, and associated symptoms (cramping, fever, weight loss)

2. Rule out infection: Obtain stool studies for bacterial pathogens, C. difficile, and parasites (especially if acute onset) 2

3. Evaluate for malabsorption: Consider testing for:

   • Fecal elastase (pancreatic insufficiency)
   • SeHCAT scan or 7-day fecal bile acid measurement (bile acid malabsorption)
   • Celiac serology if not previously done
   • Breath testing for SIBO or lactose intolerance

4. Review medication timing: Determine if symptoms began after Latuda initiation or dose increase

5. Consider empiric loperamide: Safe to initiate at 4 mg initially, then 2 mg after each loose stool (maximum 16 mg/day) while awaiting test results 2, 3, 2

Important Caveats

• Latuda-induced diarrhea, when it occurs, is typically mild (grade 1-2) and does not usually require drug discontinuation 1

• The yellow color suggests a specific pathophysiological process beyond simple drug-induced diarrhea and should not be dismissed as a benign medication side effect

• Latuda has a favorable metabolic profile compared to many other atypical antipsychotics, with minimal effects on weight and glucose 4, 5, 6, making it less likely to cause metabolic complications that might indirectly affect stool characteristics

• Most Latuda side effects (somnolence, akathisia, nausea) are transitory and occur early in treatment 4, 5, so persistent yellow diarrhea weeks after stable dosing is particularly unlikely to be drug-related

In summary, while Latuda can cause diarrhea, the yellow coloration warrants investigation for alternative etiologies rather than simple attribution to the medication.